MRI: One-stop shop for the comprehensive assessment of pulmonary arterial hypertension?

Chest

Volumn 132, Issue 1, 2007, Pages 2-5

  Nagendran, Jayan ^a,b   Michelakis, Evangelos ^a,c  

^a Department of Pulmonary Hypertension ^*

^b Pulmonary Hypertension Program

^c UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; SILDENAFIL;

CLINICAL ASSESSMENT; EDITORIAL; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE FUNCTION; LUNG CIRCULATION; LUNG PERFUSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RELAXATION TIME;

EID: 34447506670     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-0563     Document Type: Article

References (19)

1. Michelakis ED. Spatio-temporal diversity of apoptosis within the vascular wall in pulmonary arterial hypertension: heterogeneous BMP signaling may have therapeutic implications. Circ Res 2006; 98:172-175
2. Zhao YD, Courtman DW, Deng Y, et al. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease. Circ Res 2005; 96:442-450
3. Cowan KN, Heilbut A, Humpl T, et al. Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat Med 2000; 6:698-702
4. McMurtry MS, Archer SL, Altieri DC, et al. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J Clin Invest 2005; 115:1479-1491
5. McMurtry MS, Bonnet S, Wu X, et al. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis. Circ Res 2004; 95:830-840
6. Voelkel NF, Quaife RA, Leinwand LA, et al. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 2006; 114:1883-1891
7. Zaffran S, Kelly RG, Meilhac SM, et al. Right ventricular myocardium derives from the anterior heart field. Circ Res 2004; 95:261-268
8. Tandri H, Daya SK, Nasir K, et al. Normal reference values for the adult right ventricle by magnetic resonance imaging. Am J Cardiol 2006; 98:1660-1664
9. Dambrauskaite V, Delcroix M, Claus P, et al. The evaluation of pulmonary hypertension using right ventricular myocardial isovolumic relaxation time. J Am Soc Echocardiogr 2005; 18:1113-1120
10. Gan C, Holverda S, Marcus T, et al. Right ventricular diastolic dysfunction and acute effects of sildenafil in pulmonary hypertension patients. Chest 2007; 132:11-17
11. McLaughlin W, Presberg KW, Doyle RL, et al. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126:78S-92S
12. Michelakis E, Tymchak W, Lien D, et al. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation 2002; 105:2398-2403
13. Wilkins MR, Paul GA, Strange JW, et al. Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study. Am J Respir Crit Care Med 2005; 171: 1292-1297
14. Mereles D, Ehlken N, Kreuscher S, et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation 2006; 114:1482-1489
15. Nagendran J, Archer S, Gurtu V, et al. Phosphodiesterase Type 5 is highly expressed in the hypertrophied human right ventricle: direct implications for patients with pulmonary hypertension. Circulation 2006; 114s:ii-667
16. Hill JM, Dick AJ, Raman VK, et al. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 2003; 108:1009-1014
17. Sosnovik DE, Schellenberger EA, Nahrendorf M, et al. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn Reson Med 2005; 54:718-724
18. Ghofrani HA, Seeger W, Grimminger F. Imatinib for the treatment of pulmonary arterial hypertension. N Engl J Med 2005; 353:1412-1413
19. Kerkela R, Grazette L, Yacobi R, et al. Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nat Med 2006; 12:908-916